Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia

NICE

20 April 2021 - Acalabrutinib, taken as a twice daily tablet, is recommended as an option for adults with untreated chronic lymphocytic leukaemia.

A brand new oral treatment for an incurable blood cancer has today been recommended for NHS use by NICE.

Read NICE press release

Michael Wonder

Posted by:

Michael Wonder